Burning Rock Biotech Limited Equity Method Investment, Other than Temporary Impairment
Burning Rock Biotech Limited (BNR) reported Equity Method Investment, Other than Temporary Impairment of CNY 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-04-28
CNY
| Period end | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|
| 2025-12-31 | 0.00 CNY 20-F · filed 2026-04-28 |
| 2024-12-31 | 247.00K CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 0.00 CNY 20-F · filed 2026-04-28 |
| 2022-12-31 | 0.00 CNY 20-F · filed 2025-04-29 |
| 2021-12-31 | 0.00 CNY 20-F · filed 2022-04-29 |
| 2020-12-31 | 0.00 CNY 20-F · filed 2021-03-23 |
USD
| Period end | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-04-28 |
| 2024-12-31 | $34.00K 20-F · filed 2025-04-29 |